20 Site Credits
You currently have 0 Site Credits in your account. Purchase Site Credits

Available in Packages/Products: PRESENT Complete Podiatric CME Online

Section: CME Category: Practice Management Strategy

Risk Management and Mitigating Risk Opportunities for The Podiatric Physician

Robert Smith, DPM

"The purpose of this presentation will allow for the participate to appreciate the central theme of risk management allowing for a patient safe environment when podiatric physicians conduct infection control, inform consent, time out procedures, and opioid prescribing. An appraisal of risks and risk mitigating tools as found in clinical base medical as well as legal text are provided so that the podiatric physician may develop mitigating tools to patient harm when conduct duties centered on infection control, providing inform consent, surgical time out procedures and opioid ordering and prescribing. The goal of this hour-long presentation is to fulfill the one-hour Risk Management CPME requirement for podiatric physicians licensed in the state of Florida."

For Florida podiatrists, no more than 8 hours (20% of the hours of continuing education required per biennium) of home study programs may be credited toward the licensee’s biennial continuing education requirement for license renewal. A test must be completed and passed demonstrating competency in the topic taught in order to receive credit for the course.

Completion (Credits: 1.25) CME (Credits: 1)

Method of Participation

Complete the 4 steps to earn your CE/CME credit:

  1. Complete the Pre-Test
  2. View the Lecture
  3. Complete the Quiz (Min. 70% Passing Score)
  4. Complete the program Survey
Goals and Objectives
  1. To present data congruent with state requirements for allowing an appreciation of the possibility for risk assumed when ordering and prescribing opioids within our profession.
  2. Further, this presentation is intended to comply with state mandated continuing education for risk management by allowing for appreciating the risk during infectious control. Inform consent, surgical time out, and during opioid prescribing and as well as
  3. During this presentation ---I will present objective definitions for risk management and risk mitigation strategies
  4. Also, both medical and legal theories relying on clinical base evidence- publish best practice guidelines and integrating both Federal and State recommendations and guidelines for risk management demonstrating avoidance strategies, techniques and behavi
  • Accreditation and Designation of Credits
  • Completion (Credits: 1.25)

    This lecture has been approved for the PRESENT Podiatric Education Online curriculum by the Council of Teaching Hospitals Residency Education Review Committee.

    Release Date: 07/02/2021 Expiration Date: 12/31/2023

  • CME (Credits: 1)

    PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1 continuing education contact hours

    Release Date: 07/02/2021 Expiration Date: 12/31/2022

  • Author
  • Robert Smith, DPM

    Studying Opioid Harm, Inc (501.3c Non-profit Organization)
    Ormond Beach, FL

  • System Requirements
  • To view Lectures online, the following specs are required:

    • Broadband Internet
    • Browsers must have javascript enabled. Most browsers have this feature enabled by default.
    • Any PDF reader. Download Adobe PDF (Free) to print certificates.
    Supported Browsers:
    • Chrome
    • Firefox
    • Microsoft Edge
    • Safari
    Supported Mobile OS:
    • Apple iOS 13+
    • Android 10+
  • Disclosure Information
  • It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.

    ---

    Robert Smith has nothing to disclose.